Alport/Haematuria Panel

Nephrology

Alport/Haematuria Panel

Overview

Test Name
Alport/Haematuria Panel
Test Code
NEE1002
Test Category
Gene Panels
Test Subcategory
Nephrology
Disease(s) Targeted
Alport/haematuria
Who Is The Test For?
Patients with a family history, clinical suspicion, or diagnosis of alport/haematuria.
Test Approach

Whole exome sequencing (WES) with in silico gene panel analysis.

No. of Genes
5
Panel Content
COL4A1, COL4A3, COL4A4, COL4A5, MYH9
Deliverables
Turnaround Time

~3-6 weeks*

Specimen Requirements

For detailed information about the sample requirements, please consult our clinical sample requirements page.

*Turnaround times are estimated from receipt of satisfactory specimen and test request form at the laboratory to release of clinical report. The turnaround time may vary depending on the nature of the specimen and the complexity of the investigation required. The above table is only a guideline and the complexity of a case and the requirement for further investigations may change this.

About Alport/haematuria

Alport syndrome and related haematuria conditions are genetic kidney disorders that can lead to blood in the urine (haematuria), kidney failure, hearing loss and eye problems.

Alport syndrome is an inherited disorder that damages the glomerular basement membrane (GBM) in the kidneys. This damage impairs the kidneys' filtering ability, causing blood and protein to leak into the urine (haematuria and proteinuria, respectively). In the absence of treatment, this leads to progressive loss of kidney function and can result in kidney failure. The syndrome also causes sensorineural hearing loss and eye abnormalities. Alport syndrome is a rare disease; it affects approximately 1 in 5,000 to 1 in 50,000 people, depending on the population and study. It is caused by genetic variants in genes that code for type IV collagen: most commonly in COL4A5 (X-linked inheritance), but also in COL4A3 and COL4A4 (both autosomal dominant and recessive inheritance).

Gene Panel Workflow

Order a test using our clinical portal

Preview Documents

©2023 Genseq All Rights Reserved.

Terms & Conditions
Privacy Policy
Cookie Policy
Cookie Preferences